|

A Study to Evaluate Coronary Atherosclerosis in Patients With Diabetes Mellitus

RECRUITINGSponsored by Asan Medical Center
Actively Recruiting
SponsorAsan Medical Center
Started2021-08-24
Est. completion2025-12-31
Eligibility
Age19 Years+
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT05801432

Summary

The purpose of this study is to evaluate the natural history of coronary atherosclerosis development and progression over time by CCTA and to identify risk factors attributable to the development of coronary atherosclerosis in a Korean DM population.

Eligibility

Age: 19 Years+Healthy volunteers accepted
Inclusion Criteria:

* Age 19 years or older
* Asymptomatic patients with type 2 DM who had undergone initial CCTA evaluation at the Diabetes Center of the Asan Medical Center between February 2008 and June 2012
* Willing and able to provide informed written consent

Exclusion Criteria:

* Blood test results that the Creatinine level exceeds 1.5 mg/dL
* A person with a history of anaphylaxis or allergic shock associated with a contrast medium
* Pregnant women
* Unable to undergo follow-up CCTA
* Uninterpretable CCTA

Conditions3

DiabetesDiabetes MellitusHeart Disease

Browse More Trials

Heart Disease trialsDiabetes trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.